Lymphoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lymphoma stocks.

Lymphoma Stocks Recent News

Date Stock Title
May 3 ALRN Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
May 3 PSTX Broker Revenue Forecasts For Poseida Therapeutics, Inc. (NASDAQ:PSTX) Are Surging Higher
May 3 JAZZ Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
May 3 CRDF Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript
May 2 CRDF Cardiff Oncology GAAP EPS of -$0.22 beats by $0.03, revenue of $0.2M beats by $0.14M
May 2 CRDF Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
May 2 ALRN Aileron reports data from Cohort 1 of Phase Ib inhaled IPF treatment trial
May 2 PSTX Xyphos and Poseida to develop allogeneic cell therapies for cancer
May 2 JAZZ Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript
May 1 JAZZ Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 1 CRDF Cardiff Oncology Q1 2024 Earnings Preview
May 1 JAZZ Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation
May 1 JAZZ Jazz Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY24 outlook
May 1 BGNE BeiGene, AbbVie patent spat to get trial from USPTO appeals board
May 1 JAZZ Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
May 1 JAZZ Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
May 1 PSTX Poseida gains on cell therapy pact with Astellas
May 1 ALRN Aileron announces pricing of underwritten registered direct offering priced at-the-market under Nasdaq rules of up to about $40M
May 1 PSTX Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
May 1 ALRN Aileron Therapeutics announces positive data from its early stage pulmonary fibrosis treatment trial
Lymphoma

Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The name often refers to just the cancerous versions rather than all such tumors. Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The enlarged lymph nodes are usually painless. The sweats are most common at night.There are dozens of subtypes of lymphomas. The two main categories of lymphomas are Hodgkin's lymphomas (HL) and the non-Hodgkin lymphomas (NHL). The World Health Organization (WHO) includes two other categories as types of lymphoma: multiple myeloma and immunoproliferative diseases. About 90% of lymphomas are non-Hodgkin lymphomas. Lymphomas and leukemias are a part of the broader group of tumors of the hematopoietic and lymphoid tissues.Risk factors for Hodgkin lymphoma include infection with Epstein–Barr virus and a history of the disease in the family. Risk factors for common types of non-Hodgkin lymphomas include autoimmune diseases, HIV/AIDS, infection with human T-lymphotropic virus, immunosuppressant medications, and some pesticides. Eating large amounts of red meat and tobacco smoking may also increase the risk. Diagnosis, if enlarged lymph nodes are present, is usually by lymph node biopsy. Blood, urine, and bone marrow testing may also be useful in the diagnosis. Medical imaging may then be done to determine if and where the cancer has spread. Lymphoma most often spreads to the lungs, liver, and brain.

Browse All Tags